2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$45.86+$1.66 (+3.77%)
Price as of Oct 02, 2026 5:07 PM EDT- $3.6BMarket Cap
- 24.02%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$45.86+$1.66 (+3.77%)
VCYT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.19 | ||
Change | -$1.85 (-4.02%) | ||
Open | $45.66 | ||
High | $47.14 | ||
Low | $44.18 | ||
Previous Close | $46.04 | ||
Volume | 1,427,327 | ||
30-Day Average Volume | 1,441,146 | ||
1-Week Change | -8.96% | ||
1-Month Change | 1.75% | ||
1-Year Change | 24.02% | ||
3-Year Change | 97.90% | ||
5-Year Change | -5.33% | ||
Fundamentals | |||
Shares Outstanding | 80.4M | ||
Total Assets | $1.5B | ||
Market Cap | $3.6B | ||
Enterprise Value | $3.3B | ||
Period: QTR TTM FY | |||
Revenue | $145.7M | ||
Net Income | $25.5M | ||
Free Cash Flow | $43.0M | ||
EBIT | $26.5M | ||
EBITDA | $31.4M | ||
Net Working Capital | $512.0M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 104 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 3 | ||
P/E | 143 | ||
PEG | -12 | ||
Price/Free Cash Flow | 83 | ||
Price/Operating Cash Flow | 78 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue